Watch Syntara Ltd CEO Gary Phillips Present At JustStocks ‘Stars in 2024’ Investor Event

Chief Executive Officer Gary Phillips presented at ‘Stars in 2024.’ Syntara Ltd (ASX: SNT) is a clinical-stage drug development company that is in Phase 2 clinical trial recruitment evaluating SNT-5505, in combination with standard of care, treating the bone marrow cancer myelofibrosis.

Articles of Interest